Sana Biotechnology Stock Short Ratio
| SANA Stock | USD 10.04 0.04 0.40% |
Sana Biotechnology fundamentals help investors to digest information that contributes to Sana Biotechnology's financial success or failures. It also enables traders to predict the movement of Sana Stock. The fundamental analysis module provides a way to measure Sana Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sana Biotechnology stock.
Sana | Short Ratio |
Sana Biotechnology Company Short Ratio Analysis
Sana Biotechnology's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Sana Biotechnology Short Ratio | 19.99 X |
Most of Sana Biotechnology's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sana Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Sana Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Sana Biotechnology is extremely important. It helps to project a fair market value of Sana Stock properly, considering its historical fundamentals such as Short Ratio. Since Sana Biotechnology's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sana Biotechnology's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sana Biotechnology's interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Sana Biotechnology has a Short Ratio of 19.99 times. This is much higher than that of the Biotechnology sector and 169.77% higher than that of the Health Care industry. The short ratio for all United States stocks is notably lower than that of the firm.
Sana Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sana Biotechnology's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sana Biotechnology could also be used in its relative valuation, which is a method of valuing Sana Biotechnology by comparing valuation metrics of similar companies.Sana Biotechnology is currently under evaluation in short ratio category among related companies.
Sana Biotechnology Institutional Holders
Institutional Holdings refers to the ownership stake in Sana Biotechnology that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Sana Biotechnology's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sana Biotechnology's value.| Shares | Baker Bros Advisors Lp | 2023-12-31 | 2 M | Goldman Sachs Group Inc | 2023-12-31 | 1.7 M | Suvretta Capital Management, Llc | 2023-12-31 | 1.6 M | Capital World Investors | 2023-12-31 | 1.5 M | Jpmorgan Chase & Co | 2023-12-31 | 1.2 M | Massachusetts Financial Services Company | 2023-12-31 | 1.1 M | Northern Trust Corp | 2023-12-31 | 887 K | Charles Schwab Investment Management Inc | 2023-12-31 | 748.8 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 733.4 K | Fmr Inc | 2023-12-31 | 15.8 M | Canada Pension Plan Investment Board | 2023-12-31 | 10.2 M |
Sana Fundamentals
| Return On Equity | -0.72 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | 2.1 B | ||||
| Shares Outstanding | 221.32 M | ||||
| Shares Owned By Insiders | 9.06 % | ||||
| Shares Owned By Institutions | 84.57 % | ||||
| Number Of Shares Shorted | 26.72 M | ||||
| Price To Book | 6.86 X | ||||
| EBITDA | (294.94 M) | ||||
| Net Income | (283.25 M) | ||||
| Cash And Equivalents | 484.8 M | ||||
| Cash Per Share | 2.57 X | ||||
| Total Debt | 104.1 M | ||||
| Debt To Equity | 0.18 % | ||||
| Current Ratio | 5.09 X | ||||
| Book Value Per Share | 1.45 X | ||||
| Cash Flow From Operations | (253.58 M) | ||||
| Short Ratio | 19.99 X | ||||
| Earnings Per Share | (1.46) X | ||||
| Target Price | 12.4 | ||||
| Number Of Employees | 328 | ||||
| Beta | 1.61 | ||||
| Market Capitalization | 2.21 B | ||||
| Total Asset | 565.3 M | ||||
| Retained Earnings | (1.34 B) | ||||
| Working Capital | 149.03 M | ||||
| Net Asset | 565.3 M |
About Sana Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sana Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sana Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sana Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Sana Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sana Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sana Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sana Biotechnology Stock:Check out Sana Biotechnology Piotroski F Score and Sana Biotechnology Altman Z Score analysis. For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Sana Stock analysis
When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Sana Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sana Biotechnology. If investors know Sana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sana Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.46) | Return On Assets (0.29) | Return On Equity (0.72) |
The market value of Sana Biotechnology is measured differently than its book value, which is the value of Sana that is recorded on the company's balance sheet. Investors also form their own opinion of Sana Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Sana Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sana Biotechnology's market value can be influenced by many factors that don't directly affect Sana Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sana Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sana Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sana Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.